Skip to main navigation Skip to search Skip to main content

Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation

  • Omer Jamy
  • , Raquel Innis-Shelton
  • , Susan Bal
  • , Ravi Paluri
  • , Donna Salzman
  • , Antonio Di Stasi
  • , Luciano Costa
  • , Ruby Meredith
  • , Lawrence Lamb
  • , Kentaro Minagawa
  • , Shin Mineishi
  • , Ayman Saad

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)E396-E398
JournalAmerican Journal of Hematology
Volume96
Issue number10
DOIs
StatePublished - Oct 1 2021

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this